Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engaging communities in tuberculosis research.
Boulanger RF, Seidel S, Lessem E, Pyne-Mercier L, Williams SD, Mingote LR, Scott C, Chou AY, Lavery JV; Critical Path to TB Drug Regimens' Stakeholder and Community Engagement Workgroup. Boulanger RF, et al. Among authors: lessem e. Lancet Infect Dis. 2013 Jun;13(6):540-5. doi: 10.1016/S1473-3099(13)70042-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531390
The evolving role of advocacy in tuberculosis.
DeLuca A, Lessem E, Wegener D, Mingote LR, Frick M, Von Delft D. DeLuca A, et al. Among authors: lessem e. Lancet Respir Med. 2014 Apr;2(4):258-9. doi: 10.1016/S2213-2600(14)70035-9. Epub 2014 Mar 24. Lancet Respir Med. 2014. PMID: 24717620 No abstract available.
Real engagement with communities.
Mingote LR, Vandevelde W, Kumar B, Lessem E. Mingote LR, et al. Among authors: lessem e. Lancet Respir Med. 2015 Jan;3(1):e2. doi: 10.1016/S2213-2600(14)70309-1. Lancet Respir Med. 2015. PMID: 25593092 No abstract available.
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, Browning R, Gardiner E, Hafner R, Hesseling A, How C, Jean-Philippe P, Lessem E, Makhene M, Mbelle N, Marais B, McIlleron H, McNeeley DF, Mendel C, Murray S, Navarro E, Anyalechi EG, Porcalla AR, Powell C, Powell M, Rigaud M, Rouzier V, Samson P, Schaaf HS, Shah S, Starke J, Swaminathan S, Wobudeya E, Worrell C. Nachman S, et al. Among authors: lessem e. Lancet Infect Dis. 2015 Jun;15(6):711-20. doi: 10.1016/S1473-3099(15)00007-9. Epub 2015 May 6. Lancet Infect Dis. 2015. PMID: 25957923 Free PMC article. Review.
Compassionate and optimum use of new tuberculosis drugs.
Reed C, Mason L, Cox H, Seaworth B, Lessem E, Furin J. Reed C, et al. Among authors: lessem e. Lancet Infect Dis. 2015 Oct;15(10):1131. doi: 10.1016/S1473-3099(15)00294-7. Epub 2015 Sep 20. Lancet Infect Dis. 2015. PMID: 26461942 No abstract available.
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.
Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group. Dheda K, et al. Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2. Lancet Respir Med. 2019. PMID: 31486393 Review.
27 results